News

DuPont Nutrition & Health has added a new pharmaceutical excipient to the portfolio of ingredients for CPhI Worldwide 2014, in Paris this October.

Alchem International announced that it will continue to market and support Tropane Alkaloid APIs despite earlier reports.

CALIXAR and VirPath use new manufacturing techniques to create a vaccine for the pandemic flu, influenza A (H1N1), available in 2015.

Regulations, product protection, and cost management are top concerns of supply chain decision makers.

Merck KGaA will expand the reach of its EMD Millipore division with the purchase of life-sciences company Sigma-Aldrich.

GS1 publishes a healthcare industry guideline describing how to implement GS1 standards to support requirements of the 2013 US Drug Supply Chain Security Act.

Texas A&M dedicates national pandemic influenza vaccine manufacturing facility.

GSK is found guilty of offering bribes to doctors and is fined $489 million.

PCI's acquisition of Biotech Services International expands the packaging services provider's presence in Europe.

Bayer separates into two entities to benefit the growth and development of Bayer Life Science and MaterialScience.

The University of Limerick will be the headquarters for a new $6.4-million research and innovation center.

EMD Serono announces a collaboration with Sutro Biopharma to develop antibody drug conjugates for multiple undisclosed targets.

GPhA throws its support behind a bill to prohibit companies from using REMS practices to deter competition.

Baxter announced that its new biopharmaceutical company will be named Baxalta when the company separates into two publicly traded companies in mid-2015.

Baxter International initiated a US voluntary recall of one lot of potassium chloride injection due to mislabeled shipping carton.

FDA approved Baxter International's treatment, RIXUBIS, for the treatment of children with hemophilia B.

The Reuters Annual Pharmaceutical Factbook reveals positive outlook for pharmaceutical industry and key insights into current trends.

Regeneron Pharmaceuticals' injection for diabetic retinopathy in patients with diabetic macular edema received FDA breakthrough therapy designation on Sept. 16, 2014.

AstraZeneca's Movantik was approved by FDA in the treatment of opioid-induced constipation.

FDA releases guidance on ANDAs and PASs submissions to help applicants avoid deficiencies.

Hospira recalled one lot of heparin due to particulate matter.

A GPhA report says generic drugs saved the US health system $239 billion in 2013.

Gerresheimer will present ready-to-fill syringes, plastic packaging products, and pharmaceutical vials at CPhI 2014.

An opportunity to broaden your horizon on the latest and hottest industry trends that shape the pharmaceutical landscape.

Molecular Profiles has expanded its capsule filling capability following significant investment into new equipment at its clinical manufacturing site in the United Kingdom.

Rigaku Raman Technologies will showcase customizable handheld Raman analyzer for accurate and comprehensive raw material ID at CPhI 2014.

The countdown has begun for one of the world?s largest pharmaceutical networking events.

Bosch Packaging Technology will present four devices for processing liquid and solid pharmaceutical dosage forms at CPhI Worldwide 2014.

European Commission granted the first biosimilar insulin to receive regulatory approval in Europe.

Asterias Biotherapeutics, Cancer Research UK, and Cancer Research Technology partner for clinical trial of immunotherapy vaccine for the treatment of lung cancer.